Lexicon Pharmaceuticals, Inc.
LXRXBiotechnology
$1.42−4.05%As of Oct 30vs prior close
- Market cap
- $631.8M
- P/E (TTM)
- –
- From 52W high
- −46.21%
- EPS (LTM)
- -$0.15
- Revenue (LTM)
- $41.5M
- Net margin
- -147.38%
- Dividend yield
- 0.00%
Nomior Score
45
Steady ProfileSpeculativeBottom 39% of the scored universe
Growth36
Quality56
Value46
Momentum67
Resilience35
Growth
−5.03%revenue a year over 9 fiscal years
YE16 $79.3MLTM $41.5M
Connections
Revenue to profitQ2 YE26
The operating loss was 3835% of revenue, wider by 3848 pts on a year.
Who owns it
2funds